|
1
|
Parkin DM: Global cancer statistics in the
year 2000. Lancet Oncol. 2:533–543. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thorgeirsson SS and Grisham JW: Molecular
pathogenesis of human hepatocellular carcinoma. Nat Genet.
31:339–346. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Um TH, Kim H, Oh BK, Kim MS, Kim KS, Jung
G and Park YN: Aberrant CpG island hypermethylation in dysplastic
nodules and early HCC of hepatitis B virus-related human multistep
hepatocarcinogenesis. J Hepatol. 54:939–947. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nishida N, Nagasaka T, Nishimura T, Ikai
I, Boland CR and Goel A: Aberrant methylation of multiple tumor
suppressor genes in aging liver, chronic hepatitis and
hepatocellular carcinoma. Hepatology. 47:908–918. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Molkentin JD: The zinc finger-containing
transcription factors GATA-4, −5, and −6. Ubiquitously expressed
regulators of tissue-specific gene expression. J Biol Chem.
15(275): 38949–38952. 2000. View Article : Google Scholar
|
|
7
|
Patient RK and McGhee JD: The GATA family
(vertebrates and invertebrates). Curr Opin Genet Dev. 12:416–422.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Laverriere AC, MacNeill C, Mueller C,
Poelmann RE, Burch JB and Evans T: GATA-4/5/6, a subfamily of three
transcription factors transcribed in developing heart and gut. J
Biol Chem. 269:23177–23184. 1994.PubMed/NCBI
|
|
9
|
Fujikura J, Yamato E, Yonemura S, Hosoda
K, Masui S, Nakao K, Miyazaki Ji J and Niwa H: Differentiation of
embryonic stem cells is induced by GATA factors. Genes Dev.
16:784–789. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gao X, Sedgwick T, Shi YB and Evans T:
Distinct functions are implicated for the GATA-4, −5, and −6
transcription factors in the regulation of intestine epithelial
cell differentiation. Mol Cell Biol. 18:2901–2911. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Akiyama Y, Watkins N, Suzuki H, Jair KW,
van Engeland M, Esteller M, Sakai H, Ren CY, Yuasa Y, Herman JG and
Baylin SB: GATA-4 and GATA-5 transcription factor genes and
potential downstream antitumor target genes are epigenetically
silenced in colorectal and gastric cancer. Mol Cell Biol.
23:8429–8439. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hellebrekers DM, Lentjes MH, van den Bosch
SM, Melotte V, Wouters KA, Daenen KL, Smits KM, Akiyama Y, Yuasa Y,
Sanduleanu S, et al: GATA4 and GATA5 are potential tumor
suppressors and biomarkers in colorectal cancer. Clin Cancer Res.
15:3990–3997. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lassus H, Laitinen MP, Anttonen M,
Heikinheimo M, Aaltonen LA, Ritvos O and Butzow R: Comparison of
serous and mucinous ovarian carcinomas: Distinct pattern of allelic
loss at distal 8p and expression of transcription factor GATA-4.
Lab Invest. 81:517–526. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peters I, Gebauer K, Dubrowinskaja N,
Atschekzei F, Kramer MW, Hennenlotter J, Tezval H, Abbas M, Scherer
R, Merseburger AS, et al: GATA5 CpG island hypermethylation is an
independent predictor for poor clinical outcome in renal cell
carcinoma. Oncol Rep. 31:1523–1530. 2014.PubMed/NCBI
|
|
15
|
Guo M, House MG, Akiyama Y, Qi Y, Capagna
D, Harmon J, Baylin SB, Brock MV and Herman JG: Hypermethylation of
the GATA gene family in esophageal cancer. Int J Cancer.
119:2078–2083. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wen XZ, Akiyama Y, Pan KF, Liu ZJ, Lu ZM,
Zhou J, Gu LK, Dong CX, Zhu BD, Ji JF, et al: Methylation of GATA-4
and GATA-5 and development of sporadic gastric carcinomas. World J
Gastroenterol. 16:1201–1208. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Martin J, Afouda BA and Hoppler S:
Wnt⁄beta-catenin signalling regulates cardiomyogenesis via GATA
transcription factors. J Anat. 216:92–107. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Afouda BA, Martin J, Liu F, Ciau-Uitz A,
Patient R and Hoppler S: GATA transcription factors integrate Wnt
signalling during heart development. Development. 135:3185–3190.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jia Y, Yang Y, Liu S, Herman JG, Lu F and
Guo M: SOX17 antagonizes WNT/β-catenin signaling pathway in
hepatocellular carcinoma. Epigenetics. 5:743–749. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mayer MP: A new set of useful cloning and
expression vectors derived from pBlueScript. Gene. 163:41–46. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guo M, Akiyama Y, House MG, Hooker CM,
Heath E, Gabrielson E, Yang SC, Han Y, Baylin SB, Herman JG and
Brock MV: Hypermethylation of the GATA genes in lung cancer. Clin
Cancer Res. 10:7917–7924. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Herman JG, Graff JR, Myöhänen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: A novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA.
93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kristensen LS, Nielsen HM and Hansen LL:
Epigenetics and cancer treatment. Eur J Pharmacol. 625:131–142.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Meng F, Sun G, Zhong M, Yu Y and Brewer
MA: Anticancer efficacy of cisplatin and trichostatin A or
5-aza-2′-deoxycytidine on ovarian cancer. Br J Cancer. 108:579–586.
2013. View Article : Google Scholar : PubMed/NCBI
|
